Hyaluronidase recruits mesenchymal-like cells to the lung and ameliorates fibrosis

Citations of this article
Mendeley users who have this article in their library.


Hyaluronidases (HYALs) comprise a group of enzymes that degrade hyaluronic acid (HA). In this report, we reveal that a single intranasal inoculation of HYAL induces an increase in mononuclear cells within the bronchoalveolar space demonstrating a mesenchymal-like phenotype, expressing stem cell antigen-1 (SCA-1), CD44 and CD73 but not CD34, CD45, CD3, CD4, CD8 or CD19. This influx of mesenchymal stem cell (MSC)-like cells was dependent on leukotriene production within the lung parenchyma. These findings prompted experiments demonstrating that HYAL treatment potently blocked bleomycin-induced lung injury and fibrosis while decreasing transforming growth factor (TGF)-β production and collagen deposition. These data suggest that HYAL is a novel and promising tool to use autologous MSC-like cells in the treatment of pulmonary fibrosis. © 2011 Bitencourt et al; licensee BioMed Central Ltd.




Bitencourt, C. S., Pereira, P. A. T., Ramos, S. G., Sampaio, S. V., Arantes, E. C., Aronoff, D. M., & Faccioli, L. H. (2011). Hyaluronidase recruits mesenchymal-like cells to the lung and ameliorates fibrosis. Fibrogenesis and Tissue Repair, 4(1). https://doi.org/10.1186/1755-1536-4-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free